Ancora Advisors’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Ancora Advisors’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-5,057	Closed	-$214K	–	545
2015 Q2	$214K	Buy	+5,057	New	+$213K	0.03%	454
2015 Q1	–	Sell	-26,982	Closed	-$1.04M	–	205
2014 Q4	$908K	Buy	26,982 +57	+0.2%	+$2.01K	0.11%	220
2014 Q3	$943K	Hold	26,925	–	–	0.12%	208
2014 Q2	$885K	Hold	26,925	–	–	0.11%	216
2014 Q1	$992K	Hold	26,925	–	–	0.14%	186
2013 Q4	$1.03M	Hold	26,925	–	–	0.16%	165
2013 Q3	$738K	Hold	26,925	–	–	0.13%	185
2013 Q2	$565K	Buy	+26,925	New	+$526K	0.1%	227

Other funds holding WX

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

MICM

Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

TCA

Taconic Capital Advisors New York $229M AUM 110.07% 1-Year Est. Return

PRCM

Pine River Capital Management Minnetonka, Minnesota $32.9M AUM 4.47% 1-Year Est. Return

ACM

Apex Capital Management Dayton, Ohio $4.54B AUM 1.74% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

Ancora Advisors's WX Position: Q3 2015 in Review

Ancora Advisors sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q3 2015, closing a stake of 5,057 shares — an estimated $214K sold.

Ancora Advisors first reported a position in WX in Q2 2013 and held it in 8 quarters. The position peaked at $1.03M in Q4 2013. 151 funds tracked by Wall St. Rank hold WX as of Q3 2015.

Ancora Advisors reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q3 2015 after selling out during the quarter.
Ancora Advisors sold 5,057 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q3 2015, an estimated $214K.
Ancora Advisors first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2013 and held it in 8 quarters.
Ancora Advisors's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $1.03M in Q4 2013.
151 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q3 2015.

Based on Ancora Advisors's 13F filing for Q3 2015, filed 30 Oct 2015.